186 related articles for article (PubMed ID: 24991576)
1. In silico molecular docking and in vitro antidiabetic studies of dihydropyrimido[4,5-a]acridin-2-amines.
Bharathi A; Roopan SM; Vasavi CS; Munusami P; Gayathri GA; Gayathri M
Biomed Res Int; 2014; 2014():971569. PubMed ID: 24991576
[TBL] [Abstract][Full Text] [Related]
2. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
3. Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase.
Altowyan MS; Barakat A; Al-Majid AM; Al-Ghulikah HA
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242688
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies.
Rafique R; Khan KM; Arshia ; Kanwal ; Chigurupati S; Wadood A; Rehman AU; Karunanidhi A; Hameed S; Taha M; Al-Rashida M
Bioorg Chem; 2020 Jan; 94():103195. PubMed ID: 31451297
[TBL] [Abstract][Full Text] [Related]
5. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.
Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866
[TBL] [Abstract][Full Text] [Related]
6.
Osman W; Ismail EMOA; Shantier SW; Mohammed MS; Mothana RA; Muddathir A; Khalid HS
J Recept Signal Transduct Res; 2021 Apr; 41(2):159-169. PubMed ID: 32718219
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM
Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061
[TBL] [Abstract][Full Text] [Related]
8. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro
Algethami FK; Saidi I; Abdelhamid HN; Elamin MR; Abdulkhair BY; Chrouda A; Ben Jannet H
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500647
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
10. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies.
Yousuf H; Shamim S; Khan KM; Chigurupati S; Kanwal ; Hameed S; Khan MN; Taha M; Arfeen M
Bioorg Chem; 2020 Mar; 96():103581. PubMed ID: 31978686
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of epigallocatechin (EGC) analogs selective to inhibit α-amylase over α-glucosidases via the incorporation of caffeine acid and its derivatives.
Chen W; Zhou C; Chen J; Wang M; Zhou F; Wang C; Zhang X; Zhou W
Bioorg Chem; 2022 Feb; 119():105515. PubMed ID: 34896919
[TBL] [Abstract][Full Text] [Related]
13. Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential.
Saleem F; Haider M; Khan KM; Özil M; Baltaş N; Ul-Haq Z; Qureshi U; Salar U; Taha M; Hameed S; Ullah N
Int J Biol Macromol; 2023 Jun; 241():124589. PubMed ID: 37116840
[TBL] [Abstract][Full Text] [Related]
14. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
S LS; Raghu C; H A A; P A
Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives.
Singh G; Singh A; Verma RK; Mall R; Azeem U
Comput Biol Chem; 2018 Feb; 72():45-52. PubMed ID: 29346072
[TBL] [Abstract][Full Text] [Related]
17. Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase.
Devaraj S; Yip YM; Panda P; Ong LL; Wong PWK; Zhang D; Ali Y; Judeh Z
Curr Med Chem; 2022; 29(9):1606-1621. PubMed ID: 34455958
[TBL] [Abstract][Full Text] [Related]
18. Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids.
Sun H; Song X; Tao Y; Li M; Yang K; Zheng H; Jin Z; Dodd RH; Pan G; Lu K; Yu P
Future Med Chem; 2018 May; 10(9):1055-1066. PubMed ID: 29676183
[TBL] [Abstract][Full Text] [Related]
19. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
20. Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach.
Dubey K; Dubey R; Gupta R; Gupta A
Curr Comput Aided Drug Des; 2021; 17(2):307-313. PubMed ID: 32208122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
